查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629267

血浆治疗市场，按产品类型、来源、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Plasma Therapy Market, By Product Type, By Source, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 393 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年血浆治疗市场规模为4.6889亿美元，2024年至2032年复合年增长率为14.5%。

血浆治疗市场-市场动态

自体免疫疾病盛行率上升推动血浆治疗市场成长

由于自体免疫疾病的盛行率不断上升，影响了全球数百万人，因此对血浆治疗的需求不断增加。据美国自体免疫相关疾病协会称，近 5,000 万美国人患有自体免疫疾病，其中类风湿性关节炎和红斑性狼疮等疾病变得更加常见。免疫球蛋白和凝血因子等血浆衍生疗法透过增强免疫系统和预防器官损伤来控制这些疾病至关重要。此外，血浆分离技术的不断进步和血浆捐赠计划的不断增加进一步支持了市场的扩张。随着自体免疫疾病预计在全球范围内增加，血浆疗法市场预计在未来几年将显着成长。

血浆治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 14.5% 左右的复合年增长率成长

根据产品类型细分，预计 Pure PRP 将在 2023 年显示最大的市场份额

依来源细分，2023年自体血浆为主导类型

按地区划分，北美是 2023 年的主要收入来源

血浆治疗市场-細項分析：

全球血浆治疗市场根据产品类型、来源、应用、最终用户和地区进行细分。

依产品类型，市场分为四类：纯PRP（富含血小板血浆）、富含白血球PRP、纯富含血小板纤维蛋白和富含白血球纤维蛋白。纯 PRP 因其在再生医学和美容领域的广泛应用而引领市场，其次是富含白血球的 PRP，因其增强的癒合特性而闻名。接下来是纯富含血小板的纤维蛋白，而富含白血球的纤维蛋白仍然是特定治疗中的利基选择。

市场依来源分为两类：自体血浆和异体血浆。自体血浆由于其免疫反应风险较低而领先，在大多数治疗应用中是首选。随后出现了同种异体血浆，用于某些临床治疗，但受到相容性需求和潜在的免疫相关併发症的限制。

血浆治疗市场 - 地理洞察

血浆治疗市场表现出巨大的地域差异，在先进的医疗基础设施和对血浆衍生疗法的高需求的推动下，北美引领市场。美国因其广泛的血浆捐赠网络和大量患有自体免疫疾病的人口而成为主要贡献者。欧洲紧随其后，德国和英国等国家拥有完善的血浆收集系统，并且越来越关注透过血浆疗法治疗慢性病。亚太地区正在经历快速成长，特别是在中国和印度等国家，这些国家不断增加的医疗保健投资和不断提高的医疗保健意识正在扩大血浆疗法的采用。由于医疗保健服务的增加以及对血浆治疗益处的认识不断提高，拉丁美洲、中东和非洲的需求不断增长。政府改善血浆捐赠系统的措施预计将进一步推动这些地区的市场扩张。

血浆治疗市场-竞争格局：

血浆治疗市场竞争激烈，主要参与者专注于扩大产品组合和增强血浆收集网络。市场上的主要公司包括 Grifols、CSL Behring、Octapharma、Kedrion Biopharma 和 Baxter International，它们在血浆衍生疗法领域占据主导地位。这些公司正在大力投资研发，推出新的和改进的血浆衍生产品，包括免疫球蛋白、白蛋白和凝血因子，以满足血浆疗法日益增长的需求。此外，随着公司寻求扩大其全球影响力并提高生产能力，策略合作和收购也很常见。例如，Grifols 和 CSL Behring 透过收购和区域扩张巩固了自己的地位。此外，FDA 和 EMA 等监管机构在确保血浆疗法的安全性和有效性方面发挥着至关重要的作用，创造了强调市场创新和品质控制的竞争环境。

最新进展：

2021 年 10 月，BioLife Plasma Services 在美国伍斯特开设了一个新的血浆中心，以满足对血浆衍生疗法日益增长的需求，增强其收集和提供治疗血浆的能力。

2021 年 8 月，Biotest AG 在捷克共和国开设了第六个血浆采集中心，旨在确保长期血浆供应，并透过扩大采集能力来满足对血浆衍生疗法不断增长的需求。

目录

第一章：血浆治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的血浆治疗市场片段
    • 按来源分類的血浆治疗市场片段
    • 按应用分類的血浆治疗市场片段
    • 最终用户的血浆治疗市场片段
    • 按国家/地区分類的血浆治疗市场片段
    • 按地区分類的血浆治疗市场片段
  • 竞争洞察

第 3 章：血浆治疗主要市场趋势

  • 血浆治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 血浆治疗市场限制
    • 市场限制影响分析
  • 血浆治疗市场机会
  • 血浆治疗市场未来趋势

第 4 章：血浆治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：血浆治疗市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：血浆治疗市场格局

  • 2023 年血浆治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：血浆治疗市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 纯 PRP（富含血小板血浆）
    • 富含白血球的PRP
    • 纯富含血小板的纤维蛋白
    • 富含白血球的纤维蛋白

第 8 章：血浆治疗市场 - 按来源分类

  • 概述
    • 按来源分類的细分市场占有率分析
    • 自体血浆
    • 同种异体血浆

第 9 章：血浆治疗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 骨科
    • 皮肤科
    • 牙科
    • 心臟病学

第 10 章：血浆治疗市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 研究所

第 11 章：血浆治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美血浆治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模与预测（按来源）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲血浆治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按来源）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区血浆治疗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按来源）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲血浆治疗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按来源）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲血浆疗法主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按来源）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 血浆治疗产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Arthrex, Inc.
    • Johnson & Johnson Services, Inc.
    • Thermo Fisher Scientific Inc.
    • EmCyte Corporation
    • Zimmer Biomet Holdings, Inc.
    • Terumo Corporation
    • Regen Lab SA
    • BioLife Plasma Services
    • Cesca Therapeutics Inc.
    • Aesthetic Medical International Holdings Group Ltd.
    • Dr. PRP America LLC
    • AdiStem Ltd.
    • Vivostat A/S
    • Estar Medical Ltd.
    • Stryker Corporation
    • Plasmagen BioSciences Pvt. Ltd.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4554

REPORT HIGHLIGHT

Plasma Therapy Market size was valued at USD 468.89 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

The Plasma Therapy Market involves using plasma-derived products, including immunoglobulins, clotting factors, and albumin, for treating various medical conditions, such as immune deficiencies, bleeding disorders, and autoimmune diseases. The growing demand for plasma therapy is spurred by an increasing prevalence of chronic conditions, with the World Health Organization reporting that over 350 million people worldwide suffer from autoimmune diseases. Additionally, the rising number of trauma cases and surgical interventions requiring plasma-based treatments fuel market growth. However, the market faces challenges such as the high cost of plasma collection and processing, along with limited donor availability. Despite these challenges, opportunities are emerging with advancements in plasma fractionation technology, which allows for higher yields of therapeutic proteins, and the expansion of plasma donation programs in developing regions. Furthermore, the growing adoption of plasma therapies in the treatment of COVID-19 and other infectious diseases is contributing to market expansion.

Plasma Therapy Market- Market Dynamics

Rising Prevalence of Autoimmune Diseases Drives Growth in the Plasma Therapy Market

The demand for plasma therapy is increasing due to the rising prevalence of autoimmune diseases, which affect millions globally. According to the American Autoimmune Related Diseases Association, nearly 50 million Americans suffer from autoimmune disorders, with conditions like rheumatoid arthritis and lupus becoming more common. Plasma-derived therapies, such as immunoglobulins and clotting factors, are critical in managing these diseases by boosting the immune system and preventing organ damage. Additionally, ongoing advancements in plasma fractionation technology and the growing availability of plasma donation programs are further supporting the expansion of the market. With autoimmune diseases projected to rise globally, the market for plasma therapies is expected to experience significant growth in the coming years.

Plasma Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on product type segmentation, Pure PRP was predicted to show maximum market share in the year 2023

Based on Source segmentation, Autologous Plasma was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Plasma Therapy Market- Segmentation Analysis:

The Global Plasma Therapy Market is segmented based on Product Type, Source, Application, End-User, and Region.

The market is divided into four categories based on product type: Pure PRP (Platelet-Rich Plasma), Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-rich Fibrin. Pure PRP leads the market due to its widespread use in regenerative medicine and aesthetics, followed by Leukocyte-Rich PRP, known for its enhanced healing properties. Pure Platelet-Rich Fibrin follows, with Leukocyte-rich Fibrin remaining a niche option in specific treatments.

The market is divided into two categories based on Source: Autologous Plasma and Allogeneic Plasma. Autologous plasma leads due to its lower risk of immune reactions and is preferred in most therapeutic applications. Allogeneic plasma follows, used in certain clinical treatments but limited by the need for compatibility and the potential for immune-related complications.

Plasma Therapy Market- Geographical Insights

The Plasma Therapy Market shows substantial geographical variation, with North America leading the market, driven by advanced healthcare infrastructure and high demand for plasma-derived therapies. The United States is a major contributor due to its extensive plasma donation network and a large population suffering from autoimmune diseases. Europe follows closely, with countries like Germany and the UK having well-established plasma collection systems and a growing focus on treating chronic conditions through plasma therapies. The Asia-Pacific region is experiencing rapid growth, particularly in countries like China and India, where increasing healthcare investments and rising healthcare awareness are expanding the adoption of plasma therapies. Latin America and the Middle East & Africa are witnessing growing demand due to rising healthcare access and increasing awareness about plasma therapy benefits. Government initiatives to improve plasma donation systems are expected to further drive market expansion in these regions.

Plasma Therapy Market- Competitive Landscape:

The Plasma Therapy Market is highly competitive, with key players focusing on expanding their product portfolios and enhancing plasma collection networks. Major companies in the market include Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and Baxter International, which dominate the plasma-derived therapies sector. These companies are investing heavily in research and development to introduce new and improved plasma-derived products, including immunoglobulins, albumin, and clotting factors, to cater to the increasing demand for plasma therapies. Additionally, strategic collaborations and acquisitions are common as companies seek to expand their global reach and enhance production capabilities. For example, Grifols and CSL Behring have strengthened their positions through acquisition and regional expansion. Moreover, regulatory bodies like the FDA and EMA play a crucial role in ensuring the safety and efficacy of plasma therapies, fostering a competitive environment that emphasizes innovation and quality control in the market.

Recent Developments:

In October 2021, BioLife Plasma Services opened a new plasma center in Worcester, United States, to address the increasing demand for plasma-derived therapies, enhancing their capacity to collect and provide plasma for treatments.

In August 2021, Biotest AG opened its sixth plasma collection center in the Czech Republic, aiming to secure a long-term plasma supply and meet the growing demand for plasma-derived therapies through expanded collection capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMA THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Arthrex, Inc.
  • Johnson & Johnson Services, Inc.
  • Thermo Fisher Scientific Inc.
  • EmCyte Corporation
  • Zimmer Biomet Holdings, Inc.
  • Terumo Corporation
  • Regen Lab SA
  • BioLife Plasma Services
  • Cesca Therapeutics Inc.
  • Aesthetic Medical International Holdings Group Ltd.
  • Dr. PRP America LLC
  • AdiStem Ltd.
  • Vivostat A/S
  • Estar Medical Ltd.
  • Stryker Corporation
  • Plasmagen BioSciences Pvt. Ltd.
  • Others

GLOBAL PLASMA THERAPY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pure PRP (Platelet-Rich Plasma)
  • Leukocyte-Rich PRP
  • Pure Platelet-Rich Fibrin
  • Leukocyte-rich Fibrin

GLOBAL PLASMA THERAPY MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Plasma
  • Allogeneic Plasma

GLOBAL PLASMA THERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Orthopedics
  • Dermatology
  • Dentistry
  • Cardiology

GLOBAL PLASMA THERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Research Institutes

GLOBAL PLASMA THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Plasma Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Plasma Therapy Market Snippet by Product Type
    • 2.1.2. Plasma Therapy Market Snippet by Source
    • 2.1.3. Plasma Therapy Market Snippet by Application
    • 2.1.4. Plasma Therapy Market Snippet by End-User
    • 2.1.5. Plasma Therapy Market Snippet by Country
    • 2.1.6. Plasma Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Plasma Therapy Key Market Trends

  • 3.1. Plasma Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Plasma Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Plasma Therapy Market Opportunities
  • 3.4. Plasma Therapy Market Future Trends

4. Plasma Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Plasma Therapy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Plasma Therapy Market Landscape

  • 6.1. Plasma Therapy Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Plasma Therapy Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Pure PRP (Platelet-Rich Plasma)
    • 7.1.3. Leukocyte-Rich PRP
    • 7.1.4. Pure Platelet-Rich Fibrin
    • 7.1.5. Leukocyte-rich Fibrin

8. Plasma Therapy Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2023 & 2032 (%)
    • 8.1.2. Autologous Plasma
    • 8.1.3. Allogeneic Plasma

9. Plasma Therapy Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Orthopedics
    • 9.1.3. Dermatology
    • 9.1.4. Dentistry
    • 9.1.5. Cardiology

10. Plasma Therapy Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Research Institutes

11. Plasma Therapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Plasma Therapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Plasma Therapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Plasma Therapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Plasma Therapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Plasma Therapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Plasma Therapy Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arthrex, Inc.
    • 12.2.2. Johnson & Johnson Services, Inc.
    • 12.2.3. Thermo Fisher Scientific Inc.
    • 12.2.4. EmCyte Corporation
    • 12.2.5. Zimmer Biomet Holdings, Inc.
    • 12.2.6. Terumo Corporation
    • 12.2.7. Regen Lab SA
    • 12.2.8. BioLife Plasma Services
    • 12.2.9. Cesca Therapeutics Inc.
    • 12.2.10. Aesthetic Medical International Holdings Group Ltd.
    • 12.2.11. Dr. PRP America LLC
    • 12.2.12. AdiStem Ltd.
    • 12.2.13. Vivostat A/S
    • 12.2.14. Estar Medical Ltd.
    • 12.2.15. Stryker Corporation
    • 12.2.16. Plasmagen BioSciences Pvt. Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us